Brief: Pulse Biosciences Provides Updates With Respect To Proprietary CellFX nsPFA Cardiac Catheter And Cardiac Clamp

Pulse Biosciences

27/11/2023 14:24

Nov 27 (Reuters) - Pulse Biosciences Inc  PLSE.O :
    * PULSE BIOSCIENCES INC - PROVIDED PROGRAMMATIC UPDATES WITH
RESPECT TO ITS PROPRIETARY CELLFX NSPFA CARDIAC CATHETER AND
CARDIAC CLAMP
    * PULSE BIOSCIENCES INC - ROBERT W. DUGGAN, HAS INFORMED
MANAGEMENT THAT HE IS EVALUATING ONE OR MORE POTENTIAL MARKET
PURCHASES OF COMPANY COMMON STOCK
    * PULSE BIOSCIENCES INC - HAS SUBSTANTIALLY COMPLETED ALL
REQUIRED
ACTIVITIES TO COMMENCE ITS PLANNED CATHETER ABLATION FEASIBILITY
STUDY
    * PULSE BIOSCIENCES - CO HAS CLEARED PURSUANT TO ITS INSIDER
TRADING POLICY, GIVING DUGGAN THROUGH END OF DEC 11 TO PURCHASE
UP TO ONE MILLION COMMON SHARES


Further company coverage:  PLSE.O 

 ((Reuters.Briefs@thomsonreuters.com;))